The results of a rapid, direct blood culture disk susceptibility test indicated that antimicrobial chemotherapy should be changed in 48 of 173 patients with bacteremia. In 32 patients (66.6%), the indicated change was made approximately 24 h sooner than if conventional, nonrapid susceptibility tests had been used to guide therapy.
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It is generally assumed that, if the results of clinical microbiological analyses are to contribute in a meaningful way to the diagnosis, management, and prognosis of patients with infectious diseases, they must be made available to the clinician in a clinically relevant time frame. In some instances, the clinical utility of information provided by the diagnostic microbiology laboratory is significantly diminished by the length of time it takes to generate that information. Recognizing 
